Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 2.75 | 0.00% | 0.00 |
ARMP closed unchanged on Monday, July 1, 2024, on 22 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Crossed Above 20 DMA | Bullish | -0.72% | |
| Crossed Above 50 DMA | Bullish | -0.72% |
| Alert | Time |
|---|---|
| 20 DMA Support | 3 days ago |
| Non-ADX 1,2,3,4 Pullback Entry | 3 days ago |
| 1,2,3, Pullback Entry | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| 10 DMA Resistance | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.2565 |
| 52 Week Low | 1.0701 |
| Average Volume | 12,776 |
| 200-Day Moving Average | 2.93 |
| 50-Day Moving Average | 2.70 |
| 20-Day Moving Average | 2.76 |
| 10-Day Moving Average | 2.80 |
| Average True Range | 0.21 |
| RSI (14) | 49.49 |
| ADX | 35.74 |
| +DI | 24.02 |
| -DI | 14.12 |
| Chandelier Exit (Long, 3 ATRs) | 2.58 |
| Chandelier Exit (Short, 3 ATRs) | 3.21 |
| Upper Bollinger Bands | 2.96 |
| Lower Bollinger Band | 2.56 |
| Percent B (%b) | 0.48 |
| BandWidth | 14.34 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0016 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.92 | ||||
| Resistance 3 (R3) | 2.90 | 2.83 | 2.89 | ||
| Resistance 2 (R2) | 2.83 | 2.79 | 2.84 | 2.88 | |
| Resistance 1 (R1) | 2.79 | 2.76 | 2.81 | 2.81 | 2.87 |
| Pivot Point | 2.72 | 2.72 | 2.73 | 2.73 | 2.72 |
| Support 1 (S1) | 2.68 | 2.68 | 2.70 | 2.70 | 2.63 |
| Support 2 (S2) | 2.61 | 2.65 | 2.62 | 2.62 | |
| Support 3 (S3) | 2.57 | 2.61 | 2.61 | ||
| Support 4 (S4) | 2.59 |
